Omixon focuses on disrupting established molecular diagnostic markets with exciting new products and approaches to business.
The fastest sequencing-based HLA genotyping method
NanoTYPE™ is a nanopore-based long-read sequencing technology offering a revolutionary change in the clinical routine of HLA genotyping.
Monitoring absolute quantity of donor derived cfDNA
HoloGRAFT™ is a the first laboratory kit monitoring absolute quantity of donor derived cfDNA with short turnaround time- from DNA to results in 3 hours.
Multiplexing for HLA Experts
OmniType is a Multiplex Assay and Software product for use on Illumina sequencing platforms and offers a revolutionary single working-day workflow that allows processing of samples from DNA to Library in less than 6 hours.
Digital PCR For Exceptional Sensitivity
Digital PCR (dPCR) represents a technological refinement of the conventional PCR method, providing exceptional sensitivity in detection of low-abundant templates. The crucial step consists in subdividing of the sample to thousands of nanoliter-sized partitions, allowing the PCR reaction to be carried out in each partition individually.
The QTRACE® Analysis System is a CE IVD kit intended for routine monitoring of the levels of recipient-derived white blood cells in peripheral blood and/or bone marrow